PELNSEPiramal Enterprises Limited· PharmaceuticalsMediumNeutral
Announced Tue, 6 May · 18:16 IST

Piramal Enterprises Limited has informed the Exchange regarding Change in Director(s) of the company.

Management Changes View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Piramal Enterprises' board approved the re-appointment of three Independent Directors — Suhail Nathani, Anjali Bansal, and Kunal Bahl — for a second 5-year term starting October/November 2025, subject to shareholder approval. The board also approved the continuation of promoter Ajay Piramal as Chairman (Whole-time Director) beyond the age of 70, until the expiry of his current term on 31st March 2027. Additionally, the board appointed N.M. Raiji & Co. and Chhajed & Doshi as new Joint Statutory Auditors for 3 years (from the 78th AGM to the 81st AGM in 2028), replacing outgoing auditors Suresh Surana & Associates LLP and Bagaria & Co LLP, who are completing their term. N.L. Bhatia & Associates was also appointed as Secretarial Auditor for a 5-year term.

Likely market impact

These are largely routine governance actions — independent director continuity, statutory auditor rotation as required by regulations, and promoter leadership continuation. No material red flags; all changes are subject to shareholder approval at the upcoming AGM and unlikely to impact the stock price significantly.